Trellus Health plc (TRLS) ORD GBP0.0006
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.68p
0.70p
6.05p
£1.09 million
0.68p
0.65p
0.63p
n/a
0.03p (3.57%) Previous:
0.03p
174,732
n/a
30,000
Performance
| 1 week 1W | 0% | 1 year 1Y | 85% |
|---|---|---|---|
| 1 month 1M | 0% | 2 years 2Y | 93.86% |
| 3 months 3M | 46% | 3 years 3Y | 98.82% |
| 6 months 6M | 59.09% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue ($m) | 0.02 | 0.02 |
| Profit before tax ($m) | (6.34) | (8.81) |
| Adjusted EPS (¢): | (0.04) | (0.05) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Trellus Health signs deal with large US health plan
28 February 2024 12:51
-
Trellus Health launches consumer offering for IBS sufferers
17 February 2023 16:24
-
Trellus Health expecting full-year loss in line with expectations
20 December 2022 15:15
-
Holding(s) in Company
30 September 2024 07:00
-
Half-year Report
26 September 2024 07:00
-
Directorate Change
19 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.